Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

B&L Pulls Contact Lens Solution To Investigate Adverse Events

This article was originally published in The Gray Sheet

Executive Summary

A possible association between one of Bausch & Lomb's newest contact lens solutions - ReNu with MoistureLoc - and a rash of serious eye infections could have implications for the firm's broader eye care business, analysts say. However, the company is mounting an aggressive marketing campaign to counteract the negative momentum

You may also be interested in...



Contact Lens Care Solutions Should Require “Rubbing” – FDA Panel

All multipurpose contact lens care solutions should include directions for "rubbing" as well as rinsing to help avoid potential eye infections, including solutions previously approved with "no rub" labels on the exterior packaging, FDA's Ophthalmic Devices Panel says

Contact Lens Care Solutions Should Require “Rubbing” – FDA Panel

All multipurpose contact lens care solutions should include directions for "rubbing" as well as rinsing to help avoid potential eye infections, including solutions previously approved with "no rub" labels on the exterior packaging, FDA's Ophthalmic Devices Panel says

More Infection Reports Implicate B&L Lens Solutions; Analysts Losing Faith

Analyst sentiment is turning increasingly chilly as reports of infection mount around Bausch & Lomb's ReNu lens care line, with no resolution in sight

Related Content

UsernamePublicRestriction

Register

MT023434

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel